Meet our team

Aclipse management team has extensive experience in drug development including nonclinical and clinical development, regulatory manufacturing, and drug product introductions. Our team has a strong proven track record in business development, including in- and out-licensing, acquisitions, and collaborations. Aclipse management team members recently exited Thar Pharmaceuticals (acquired by Grünenthal GmbH) and Lev Pharmaceuticals (now Takeda).

Dame Pamela J Shaw,

Chairman of the
Clinical Advisory Board

Merit E Cudkowicz, MD

Clinical Advisor

Hiroshi Mitsumoto, MD

Clinical Advisor

Leonard H. van den Berg,

Clinical Advisor

Orla Hardiman, MD

Clinical Advisor
We're here to answer any questions.
Looking to connect with us?